Weaver C. Barksdale & Associates’s CATALENT, INC. CTLT Stock Holding History

Weaver C. Barksdale & Associates’s Portfolio CTLT Stock Details CTLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$12K	Buy	300 +35	+13%	+$1.42K	0.01%	255
2017 Q3	$11K	Sell	265 -17	-6%	-$630	0.01%	264
2017 Q2	$10K	Sell	282 -66	-19%	-$2.17K	0.01%	273
2017 Q1	$10K	Sell	348 -54	-13%	-$1.51K	0.01%	281
2016 Q4	$11K	Buy	402 +55	+16%	+$1.36K	0.02%	267
2016 Q3	$9K	Hold	347	–	–	0.02%	291
2016 Q2	$8K	Buy	347 +57	+20%	+$1.5K	0.01%	291
2016 Q1	$8K	Hold	290	–	–	0.01%	317
2015 Q4	$7K	Buy	290 +9	+3%	+$237	0.01%	336
2015 Q3	$7K	Buy	+281	New	+$8.53K	0.01%	329

Other funds holding CTLT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Weaver C. Barksdale & Associates's CTLT Position: Q4 2017 in Review

Weaver C. Barksdale & Associates increased its CATALENT, INC. (CTLT) stake by 13% in Q4 2017, buying an estimated $1.42K and bringing the position to 300 shares worth $12K. The position accounts for 0.01% of the portfolio, ranked #255.

Weaver C. Barksdale & Associates first reported a position in CTLT in Q3 2015 and has held it in 10 quarters since. 276 funds tracked by Wall St. Rank hold CTLT as of Q4 2017.

Weaver C. Barksdale & Associates held 300 shares of CATALENT, INC. worth $12K as of Q4 2017.
Weaver C. Barksdale & Associates bought 35 CATALENT, INC. shares in Q4 2017, an estimated $1.42K.
CATALENT, INC. made up 0.01% of Weaver C. Barksdale & Associates's portfolio in Q4 2017, its #255 holding.
Weaver C. Barksdale & Associates first reported a position in CATALENT, INC. in Q3 2015 and has held it in 10 quarters since.
276 funds tracked by Wall St. Rank held CATALENT, INC. as of Q4 2017.

Based on Weaver C. Barksdale & Associates's 13F filing for Q4 2017, filed 10 Jan 2018.